Dr. Minesh Mehta, MD

• Radiation Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Ndola Central Hosp/u Wisc

  Internship Hospital

• Ndola Central Hosp/u Wisc|radiation Oncology, University Of Wisconsin, Madison, Wis.

  Residency Hospital, 1988

• University Of Zambia / School Of Medicine|university Of Zambia School Of Medicine, Lusaka, Zambia

  Medical School, 1981

• Hospitalization rates from radiotherapy complications in the United States, 2022-03-14

• Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases, 2022-03-16

• Pediatric bithalamic gliomas have a distinct epigenetic signature and frequentEGFRexon 20 insertions resulting in potential sensitivity to targeted kinase inhibition, 2020-04-17

• Recent advances in managing brain metastasis [version 1; referees: 2 approved], 2018-11-09

• Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors, 2022-03-21

• Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases, 2022-01-03

• Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?, 2020-11-10

• Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases, 2018-04-12

• Zero Setup Margin Mask versus Frame Immobilization during Gamma Knife®Icon™ Stereotactic Radiosurgery for Brain Metastases, 2022-07-13

• Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases, 2021-07-22

• Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous, 2019-02-15

• Intermediate-risk meningioma: Initial outcomes from NRG Oncology RTOG 0539, 2017-10-06

• Pediatric and Adult H3 K27M-mutant Diffuse Midline Glioma Treated with the Selective DRD2 Antagonist ONC201, 2019-08-27

• NRG/RTOG 1122: phase II double-blinded, placebo-controlled study of bevacizumab with/without trebananib in patients with recurrent glioblastoma or gliosarcoma, 2020-03-10

• Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia, 2020-03-10

• Editorial: Effects of radiation therapies on brain metastases, 2023-04-13

• NRG Brain Tumor Specialists Consensus Guidelines for Glioblastoma Contouring, 2019-03-19

• Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors, 2022-06-22

• OptImal Gamma kNife lIghTnIng sOlutioN (IGNITION) score to characterize the solution space of the Gamma Knife FIP optimizer for stereotactic radiosurgery, 2023-03-01

• Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today, 2020-02-19

• Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data, 2022-04-16

• Hospitalization rates for complications due to systemic therapy in the United States, 2021-04-01

• Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy, 2021-05-02

• Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424, 2020-04-03

• Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance, 2021-11-08

• State of the Art: The evolving role of RT in combined modality therapy for GBM, 2018-03-12

• Regression of Intracranial Meningiomas Following Treatment with Cabozantinib, 2021-04-18

• Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases, 2023-01-27

• Relationship between insurance status and interhospital transfers among cancer patients in the United States, 2022-01-29

• High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539, 2019-11-29

• Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results, 2022-06-15

• Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells, 2018-01-03

• Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for spine metastasis: study protocol for a randomized controlled trial, 2020-11-23

• Survival and Prognostic Factors in Patients with Gastrointestinal Cancers and Brain Metastases: Have We Made Progress?, 2019-02-27

• Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States, 2021-11-12

• Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement, 2022-02-15

• Independently validated Sex-Specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825, 2021-11-10